X @Bloomberg - Reportify

Staff members at the US Federal Trade Commission said it appears Novo Nordisk A/S’ proposed bid for Metsera Inc. “may violate the procedural provisions” of the law that requires a premerger review. https://t.co/y1qKJUn6En ...